Marco Davila

Marco Davila is a physician-scientist specializing in cancer treatment using cell therapies. He currently holds several key positions at Roswell Park Comprehensive Cancer Center in Buffalo, New York:

1. Senior Vice President, Translational Research (since July 2022)
2. Vice Chair of Cellular Therapies, Department of Medicine (since July 2022)
3. Physician, Transplantation and Cellular Therapies Service (since July 2022)1

Dr. Davila's research focuses on developing gene-engineered cell therapies for cancer treatment, with the goal of identifying optimal therapies that can be evaluated in cancer patients.2 He is dedicated to translating innovative laboratory findings into clinical applications.

Background and Education

• MD and PhD from Duke University School of Medicine (1995-2004)
• BS in Biochemistry/Chemistry from Texas Christian University (1991-1995)12

Career Highlights

Before joining Roswell Park, Dr. Davila held positions at:

• Moffitt Cancer Center (2015-2022) as Senior Member and Associate Member
• University of South Florida (2015-2022) as Professor of Oncologic Sciences
• Vanderbilt University (2014-2015) as Assistant Professor of Medicine and Cancer Biology
• Memorial Sloan-Kettering Cancer Center (2010-2014) in various roles including Assistant Member and Research Fellow1

Expertise and Specializations

Dr. Davila specializes in:

• Cellular therapies, including stem cell transplantation and CAR-T cell therapies
• Treatment of hematologic malignancies, including leukemia, lymphoma, and multiple myeloma2

Achievements and Recognition

Throughout his career, Dr. Davila has received several honors and awards, including:

• Damon Runyon Clinical Investigator Award (2015)
• ASCI Council Young Physician-Scientist Award (2014)
• Amos Medical Faculty Development Program Scholar, American Society of Hematology (2012)2

Dr. Davila is also a member of several professional organizations, including the Society of Immunotherapy for Cancer, American Society of Hematology, and American Association for Cancer Research.2